You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Doug covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies for GenomeWeb.
The company aims to validate two diagnostic algorithms based in part on microRNA biomarkers to identify patients with moderate-to-severe disease.
The findings reveal a new layer of complexity around the role of microRNAs and highlight how race can influence their role in cancer and potentially other diseases.
The test is being positioned alongside the recently approved fungal infection panel T2Candida for the diagnosis of most sepsis-causing infections.
The company's core technology involves the use of cultured cells as biosensors to detect expression levels of genes associated with the disease.
The effort, dubbed the National Resource for Translational and Developmental Proteomics, aims to improve on the technology and train others in its use.
The grant was awarded to the University of Washington's Mary-Claire King, who won the Lasker Prize for her discovery of the breast cancer susceptibility gene BRCA1.
The company was established by a co-founder of Beeologics, which was developing RNAi treatments for bee diseases before its acquisition by Monsanto.
The company is developing a cloud-based platform for the detection, quantification, and interpretation of alternative splicing variation from NGS data.
The technique is a high-throughput FISH platform that enables the determination of the spatial location of genome regions in 3D and at large scale.
With the support of a grant from the National Cancer Institute, Vajra aims to validate the technology in samples from pancreatic cancer patients.
Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.
Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.
Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.
In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.